IRDAI proposal could cut PB Fintech earnings 10–12%; Jefferies retains Buy
PB Fintech shares have come under pressure as proposed IRDAI commission and expense rules threaten insurance-distribution economics. Jefferies cut its target price to Rs 1,540 from Rs 2,050 but kept its Buy call, citing a largely variable cost base and potential product-led upside.
What happened
IRDAI’s proposed insurance commission and expense rules could reduce PB Fintech earnings by 10-12%, Jefferies says. The broker cut its target price to Rs 1,540
Key facts
- Shares fell 34% on September 24
- 52-week low of Rs 1,207.20
- Stock down 31% in 2026
- Down 15% over six months
- Down nearly 30% over five trading sessions
- Jefferies target cut to Rs 1,540 from Rs 2,050
- Revised target implies 28% upside
- 10% commission reduction could cut earnings 10-12%
- Non-life business NPV could fall to 33-40% of original level
- Core-platform expenses of Rs 3,000 crore in FY26
- 80% of expenses variable
Why this matters
Reassess insurer partnerships and expansion opportunities around product-led revenue streams that reduce reliance on commission economics.
What to watch
- IRDAI consultation paper details, comment period, final notification date and implementation/phasing schedule.
- Whether caps apply uniformly to life, health, motor and other general-insurance products, and treatment of renewal commissions.
- Insurer disclosures on distributor payout changes, online-channel expense budgets and direct-sales strategy.
- PB Fintech quarterly disclosure of premium growth, take rate, new-policy versus renewal mix, marketing cost and adjusted EBITDA.
- Competitor behavior from other web aggregators, brokers and insurer-owned digital channels, especially changes in customer incentives and ad spending.
- Policy lapse/persistency trends, since lower upfront commissions increase the value of retained customers and renewal trails.
- Reforecast insurer-wise commission yield, renewal trails and product-level unit economics before committing incremental marketing spend.
- Accelerate mix toward renewal income, health and protection products, and cross-sell from existing Policybazaar/PaisaBazaar cohorts.
- Reduce dependence on paid acquisition by prioritizing organic search, app engagement, referral loops and insurer co-funded campaigns.
- Renegotiate commercial arrangements with insurers around conversion quality, persistency, claims support and volume-based incentives rather than headline commissions.
- Prepare investor guidance that separates one-time regulatory transition costs from sustainable post-rule contribution margins.